With the markets in the midst of a two-week correction, it seems that the recent high level of bullish sentiment has died down rather quickly. Many stocks have taken a hit recently, making it hard for investors to sit idly and watch as the markets give back several weeks of price action in a few days.

However, the general indexes remain well above their September breakout levels despite the recent weakness. While many individual names are falling with the general markets, there are still stocks that continue to look good, and refuse to give up much ground. Interestingly, I came across an entire sector that has been refusing to give up any ground over the past two weeks: the drug manufacturers.

IN PICTURES:

The drug manufacturing sector has several individual stocks that are in the midst of a strong rally, and are showing very little weakness, even as the markets continue to pull back. While the reasons can be many, if we simply focus on the price action we can see that these stocks have had outstanding moves already, and yet are seeing very little selling pressure.

Pharmasset (Nasdaq:
VRUS ) for instance, has rallied from a September low under $25, to over $40 per share in just three months. Despite the strong run, VRUS has seen very little selling pressure the past few weeks and is in the process of forming a bull flag. This is a good show of relative strength, as market participants are not selling their shares despite general weakness in the markets. Traders should monitor the flag pattern for a possible continuation move higher.

Source: StockCharts.com


Dr. Reddy's Laboratories
(NYSE:RDY ) has experienced a very similar move from $28 to $40 in about the same time as VRUS. While it has pulled back with the general markets over the past few sessions, it remains in a healthy uptrend, and has given up very little in relation to its preceding trend. RDY has pulled into its rising 20-day moving average and could find support at this level. Traders should watch to see if it can hold near this level and set an important pivot low.

Source: StockCharts.com


United Therapeutics Corporation
(Nasdaq:UTHR ) is another drug manufacturer that has not fallen very much with the general markets of the past two weeks. In fact, UTHR is close to its 52-week highs, and within 10% of all-time highs. UTHR has experienced two breakaway gaps in the past two months and didn't fill either one. This is showing strong buying pressure, as well as the fact that UTHR has not given up any ground with the recent weakness and instead is pushing toward its recent highs. Traders should monitor gap support near $58 in case of some weakness, but also the top of the current flag near $61 for a possible breakout.

Source: StockCharts.com

While Alexion Pharmaceuticals (Nasdaq:ALXN ) is technically in a tight consolidation, it is doing so even while sitting at all-time highs. This is a good show of strength as well, as it shows market participants are not selling despite ALXN hitting new highs. ALXN has been trading in a very tight range over the past two weeks and traders should be watching for a move outside of this range. A break below this range would imply a test of the bottom of the larger range near $67.50. A break above this range could take ALXN to all-time highs.

Source: StockCharts.com

Bottom Line
The drug manufacturers have managed to avert the recent weakness so far, and if the markets can attract some buyers, it may help this group continue to push higher. Market participants have been reluctant to sell this group, and this is a good show of relative strength. While the markets can certainly continue to head lower, they are starting to become oversold on several indicators and the prevailing trend remains positive. As such, traders should monitor groups like this that have continued to perform well despite recent weakness. These groups would be a good place to take a chance on a bounce back in the markets. (For more, see The Anatomy Of Trading Breakouts.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Joey Fundora did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Active Trading Fundamentals

    4 Stocks With Bullish Head and Shoulders Patterns for 2016 (PG, ETR)

    Discover analyses of the top four stocks with bullish head and shoulders patterns forming in 2016, and learn the prices at which they should be considered.
  2. Chart Advisor

    Uptrending Stocks Dwindle, a Few Remain (EW, WEC, WR)

    The number of uptrending stocks is shrinking, but here a few that remain in uptrends.
  3. Chart Advisor

    Trade Setups Based on Descending Trend Channels (LBTYK, RRC)

    These descending trend channels have provided reliable sell signals in the past, and are giving the signal again.
  4. Chart Advisor

    How Are You Trading The Breakdown In Growth Stocks? (VOOG, IWF)

    Based on the charts of these two ETFs, bearish traders will start turning their attention to growth stocks.
  5. Chart Advisor

    Breakout Opportunity Stocks: CPA, GNRC, WWE

    After a period of contracting volatility, watch for breakouts and bigger moves to come in these stocks.
  6. Chart Advisor

    3 Charts That Suggest Now Is The Time To Invest In Real Estate (VNQ, SPG,PSA)

    Real estate assets have some of the strongest uptrends around. We'll take a look at three candidates poised for a move higher.
  7. Chart Advisor

    Stocks With More Upside Due to Bear Traps (TAP, SPY)

    A bear trap is a pattern that typically leads to at least a short-term rise in prices. Here are stocks exhibiting the pattern.
  8. Active Trading Fundamentals

    New Traders: Trade the Market in 5 Steps

    New traders shouldn’t throw money at securities without knowing why prices move. Follow these five steps to tilt the odds in your favor.
  9. Chart Advisor

    Watch For a Bounce in These Emerging Markets (BRF, PEK)

    While downtrends are clearly in control of the direction of many emerging market ETFs, short-term indicators suggest a bounce higher could be in the cards.
  10. Investing Basics

    Valuation Models: Apple’s Stock Analysis With CAPM

    The capital asset pricing model, or the CAPM, estimates the expected return of an asset based on the systematic risk of the asset’s return.
RELATED FAQS
  1. What is Fibonacci retracement, and where do the ratios that are used come from?

    Fibonacci retracement is a very popular tool among technical traders and is based on the key numbers identified by mathematician ... Read Full Answer >>
  2. What are some of the most common technical indicators that back up Doji patterns?

    The doji candlestick is important enough that Steve Nison devotes an entire chapter to it in his definitive work on candlestick ... Read Full Answer >>
  3. Tame Panic Selling with the Exhausted Selling Model

    The exhausted selling model is a pricing strategy used to identify and trade based off of the price floor of a security. ... Read Full Answer >>
  4. Point and Figure Charting Using Count Analysis

    Count analysis is a means of interpreting point and figure charts to measure vertical price movements. Technical analysts ... Read Full Answer >>
  5. What assumptions are made when conducting a t-test?

    The common assumptions made when doing a t-test include those regarding the scale of measurement, random sampling, normality ... Read Full Answer >>
  6. How are double exponential moving averages applied in technical analysis?

    Double exponential moving averages (DEMAS) are commonly used in technical analysis like any other moving average indicator ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center